Biomerica Announces Proposed Underwritten Public Offering of Common Stock
IRVINE, Calif., March 02, 2023 (GLOBE NEWSWIRE) — Biomerica, Inc. (NASDAQ:BMRA) (“Biomerica”), a global provider of advanced medical products, announced today that it has commenced an underwritten public offering of its common stock. All shares of common stock in the proposed offering are being offered by Biomerica. The offering is subject to market conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.
Related news for (BMRA)
- Henry Schein and Biomerica Enter into Marketing Services Agreement for Biomerica’s inFoods® IBS Test in the U.S.
- MoBot alert highlights: NASDAQ: CYCU, NASDAQ: WHWK, NASDAQ: MIGI, NASDAQ: BMRA, NASDAQ: BIAF (10/16/25 08:00 AM)
- 24/7 Market News Snapshot 16 October, 2025 – BIOMERICA INC (NASDAQ:BMRA)
- United Arab Emirates Ministry of Health and Prevention Approves Biomerica’s Fortel® Kidney Test for Home Use
- MoBot alert highlights: NASDAQ: BTBD, NYSE: NBY, NASDAQ: BMRA, NASDAQ: LCFY, NASDAQ: AIHS (09/03/25 08:00 AM)
